News & Updates

Treatment with simvastatin appears to improve survival in some patients with cirrhosis after variceal bleed, suggests a study. The drug also reduces the incidence of new-onset, refractory ascites and its complications.

Low levels of free testosterone (FT) appear to contribute to frailty in male patients with advanced chronic liver disease (CLD), according to a study.

Treatment with carvedilol, compared with nadolol or propranolol, results in reduced rates of major decompensation events among patients with cirrhosis, a study has shown.

Treatment with lemborexant helps manage sleep disturbances in patients with liver cirrhosis, as shown in the crossover RESTORE trial.

Treatment with the thyroid hormone beta agonist resmetirom significantly improves qFibrosis continuous values (qFC), categorical stages (qFS), and individual collagen features associated with fibrosis progression at week 52 compared with placebo in patients with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH), as shown in the phase III MAESTRO-NASH trial.

Statin use may reduce the risk of cancer at several sites, including the liver, lung, colon, and rectum, especially for individuals with diabetes, as shown in a retrospective study.

High coffee intake may have protective effects on the liver, with reduced risk of cirrhosis, hepatocellular carcinoma (HCC), and liver-related mortality, as reported in a study.